Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

APEX LABS, INC

NPI: 1255608469 · TAMPA, FL 33634 · Clinical Medical Laboratory · NPI assigned 11/17/2011

$1.58M
Total Medicaid Paid
412,923
Total Claims
243,632
Beneficiaries
47
Codes Billed
2018-01
First Month
2024-07
Last Month

Provider Details

Authorized OfficialNELSON, GREG (PRESIDENT)
NPI Enumeration Date11/17/2011

Related Entities

Other providers sharing the same authorized official: NELSON, GREG

ProviderCityStateTotal Paid
INFINITI LABS, INC TAMPA FL $2.53M
NELSON-NAM A MEDICAL CORPORATION VAN NUYS CA $86K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 168,632 $220K
2019 119,121 $352K
2020 54,285 $293K
2021 47,823 $527K
2022 21,497 $182K
2023 1,227 $5K
2024 338 $287.78

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 13,914 9,703 $162K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 26,657 15,657 $156K
80325 8,924 6,225 $153K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 10,146 7,737 $144K
80339 6,876 4,347 $92K
80324 5,203 2,497 $54K
80354 12,230 7,220 $48K
80346 11,435 7,910 $42K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 6,367 3,537 $39K
80356 13,340 8,349 $38K
80348 12,226 8,413 $38K
80365 19,449 8,430 $38K
80323 5,362 3,520 $35K
80361 12,173 8,359 $34K
80321 963 621 $28K
80333 7,804 4,758 $27K
80359 13,349 8,345 $27K
80349 11,043 6,406 $26K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 2,178 1,494 $26K
80366 8,947 6,053 $25K
80373 10,809 7,221 $25K
80360 10,127 6,982 $25K
80355 8,769 5,953 $22K
80372 10,137 6,864 $22K
80367 10,529 7,282 $22K
80363 4,194 3,010 $20K
80368 10,666 4,586 $20K
80353 13,339 8,345 $19K
80336 6,223 4,394 $18K
80369 2,681 1,807 $17K
80351 4,731 3,215 $16K
80371 19,295 2,933 $15K
83992 12,246 7,573 $15K
80358 11,542 7,923 $13K
80338 11,920 4,759 $12K
80362 4,951 2,311 $11K
80344 5,961 3,393 $11K
80370 6,986 4,748 $10K
82570 7,120 4,364 $8K
80364 4,637 3,225 $7K
80342 6,230 3,669 $6K
84311 13,377 4,563 $5K
80357 5,639 3,880 $5K
80343 386 246 $2K
80345 13 12 $737.24
80335 1,817 781 $709.35
80375 12 12 $62.55